| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 0.01 | 50.0% | 98.3% |
| Total Income | 0.01 | 50.0% | 98.3% |
| Expenditure | 20.68 | 5.6% | 5.3% |
| PBT | — | ||
| Net Profit | -21.77 | 7.4% | 32.5% |
| OPM | — | ||
| NPM | — | ||
| EPS | -1.84 | 13.6% | 18.2% |
Precision BioSciences Announces Q3 2025 Financial Results
04 May 2026 · 4 May, 8:20 am
Summary
This document is a report of a press release announcement of Precision BioSciences, Inc.'s financial results for the quarter ended September 30, 2025. The full text of the press release is furnished as an exhibit to the report.
Informational and educational content only. Not investment advice.